Mark Hamner to Comorbidity
This is a "connection" page, showing publications Mark Hamner has written about Comorbidity.
Connection Strength
0.294
-
Predictors of Lifetime Suicide Attempts in Individuals With Attenuated Psychosis Syndrome. J Psychiatr Pract. 2018 05; 24(3):169-178.
Score: 0.111
-
Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol. 2003 Jan; 18(1):1-8.
Score: 0.038
-
Psychotic features in chronic posttraumatic stress disorder and schizophrenia: comparative severity. J Nerv Ment Dis. 2000 Apr; 188(4):217-21.
Score: 0.032
-
Plasma dopamine beta-hydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder. Psychiatry Res. 1998 Feb 27; 77(3):175-81.
Score: 0.028
-
Cue-dependent inhibition in posttraumatic stress disorder and attention-deficit/hyperactivity disorder. J Anxiety Disord. 2017 Oct; 51:1-6.
Score: 0.026
-
A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446.
Score: 0.025
-
Clozapine treatment for a veteran with comorbid psychosis and PTSD. Am J Psychiatry. 1996 Jun; 153(6):841.
Score: 0.024
-
Racial differences in psychotic symptoms among combat veterans with PTSD. Depress Anxiety. 2002; 16(4):157-61.
Score: 0.009